← Back

Wire · operational-macro

Clinical Site Readiness for Cell and Gene Therapies: Operational and Supply Chain ...

Published

23 September 2026

Topic

operational-macro

◆ Sectors

BiotechMedtechHealthtech Infrastructure

◆ Source

Read at appliedclinicaltrialsonline.com →

◆ Verified

Fusion42 · 23 September 2026 · Fusion42 review

Cell and gene therapies face significant operational and supply chain challenges as they scale beyond specialized academic centers into community care, requiring standardized processes, trained personnel, and integrated logistics to enable broader patient access.

This Wire brief sits within Fusion42's coverage of Biotech, Medtech and Healthtech Infrastructure.

◆ ◆ The Wire takeaway

You must treat operational readiness like a product feature to scale cell and gene therapies beyond top hospitals. Investing in coordinated logistics and digital tools now opens access to community care where most patients are.

◆ Coverage

1 source · 23 Sep 2026

◆ Related on Wire

◆ Topics

BiotechMedtechHealthtech Infrastructurecell-gene-therapysupply-chainclinical-trialshealthcare-operationslogistics